Aberdeen Asset Management plc’s Overweight Rating Reaffirmed at Barclays (ADN)
Aberdeen Asset Management plc (LON:ADN)‘s stock had its “overweight” rating reiterated by investment analysts at Barclays in a note issued to investors on Monday. They currently have a GBX 510 ($8.69) target price on the stock. Barclays’ price objective would suggest a potential upside of 13.99% from the stock’s previous close.
A number of other analysts have also recently weighed in on ADN. Analysts at BNP Paribas reiterated an “outperform” rating on shares of Aberdeen Asset Management plc in a research note on Friday, June 20th. They now have a GBX 550 ($9.37) price target on the stock. Finally, analysts at Liberum Capital initiated coverage on shares of Aberdeen Asset Management plc in a research note on Thursday, June 5th. They set a “buy” rating and a GBX 555 ($9.45) price target on the stock. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and twelve have given a buy rating to the company. Aberdeen Asset Management plc currently has a consensus rating of “Hold” and a consensus price target of GBX 471.28 ($8.03).
Shares of Aberdeen Asset Management plc (LON:ADN) opened at 449.40 on Monday. Aberdeen Asset Management plc has a 52-week low of GBX 342.60 and a 52-week high of GBX 500.00. The stock has a 50-day moving average of GBX 440.3 and a 200-day moving average of GBX 428.. The company’s market cap is £5.150 billion.
Aberdeen Asset Management PLC is a global asset management company investing across the four main asset classes of equity, fixed income, property and alternative investment strategies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.